Avara is led by a team of experienced, entrepreneurial industry leaders with proven backgrounds in pharmaceutical manufacturing, healthcare, and technical services.

Avara Pharmaceutical Services is an affiliate of the American Industrial Acquisition Corporation (www.aiac.com).

Larry P. Lee

Chief Executive Officer

Larry P. Lee is the CEO of Avara Pharmaceutical Services. He is a proven leader with over 25 years of experience in the pharmaceutical industry. He is actively involved in system integrations as well as creating added value across our sites and continents. He has a strong focus on operational excellence within all facets of solid dose manufacturing and packaging capabilities.

Larry has a unique ability to combine a successful company culture with proven business results. He has the responsibility for Avara’s global manufacturing facilities.

Larry has held various management positions in the laboratories, quality assurance, and information technologies in the pharmaceutical manufacturing space. He has been heavily involved in leading global initiatives for multiple pharmaceutical companies, including Avara. He is skilled at managing complex teams under the regulatory authority of Europe, Japan, and the United States.

Larry is a highly regarded member of the Avara Executive Committee. He has earned the respect and trust from his colleagues around the world through his professional approach, extensive knowledge, and a genuine desire to meet customer needs.

Larry holds a Bachelor of Science degree in Biological Sciences from Oklahoma State University.

Andy Glanville

Executive Vice President, Chief Financial Officer

Andy K. Glanville has more than 20 years of experience in Finance and Financial Management with his last 14 years focused in the Pharmaceutical Industry. Andy is a Chartered Institute of Management Accounts (CIMA) Qualified Manager with experience managing all aspects in the finance function, including ERP systems, manufacturing planning, budgeting as well as costing and reporting accounting in a US / Swiss GAAP environment. Andy has gained specialized expertise in manufacturing accounting, cost control, production planning / forecasting, capacity planning, standard costing, financial modelling, inventory control and cash management.

Since joining Avara’s Corporate Executive Committee as our EVP and CFO in January 2019, Andy is responsible for the financial strength of Avara Pharmaceutical Service. He works closely with the Commercial and Business Development Teams to identify and finance new project opportunities for our global sites that positions Avara for maximum profit, sustainability and growth. In addition, Andy in an integral part of the Pricing Committee that reviews and presents viable new project opportunities to the EC and managing board of AIAC for approval and capital investment.

Andy began his career with ICN and Valeant Pharmaceuticals as a finance leader in global manufacturing and the finance controller. In 2007 he assumed the role of the finance lead with Novartis Consumer Healthcare for a manufacturing network re-design project. Prior to his appointment as the EVP and CFO for Avara, Andy held financial leadership roles with Covidien Pharmaceuticals in the USA and Legacy Pharmaceuticals in Switzerland.

Andy holds a B.Comm.Acc (Hons), Economics, Law, Accountancy from The University of Birmingham, UK.

Richard V. Myer

Vice President, Business Development, North America

Richard V. Myer has over 20 years' experience within the pharmaceutical services industries focused on business development management positions.

Since joining Avara's Corporate Commercial Team in 2016 Rich has been instrumental in building and managing the North American business development team. In his position he has successfully identified and won new business opportunities for our global facilities as he continues to grow the North American business development team. Rich's team now has four business development directors, whom, along with Rich are focused on North America and responsible for driving new business to our global facilities.

Prior to Avara, Rich held business development management positions with contract service providers, including, AAI, MDS and Xcelience enabling him to develop expertise across the drug development continuum while managing teams for the last 15 years. Rich began his career conducting molecular biology research at Rush-Presbyterian-St. Luke's Medical Center in Chicago, IL.

Rich holds a BA as well as an MBA from Purdue University.

Russell B. Harris

Vice President, Business Development, Europe

Russell Harris has 20+ years of experience in the pharmaceutical industry with senior roles in Manufacturing, Procurement and Business Development with major pharmaceutical companies. In addition, he has gained extensive experience in Pharmaceutical B2B third party sales and is a proven leader capable of driving robust and innovative sourcing and selling approaches for global markets.

Since joining Avara’s Corporate Commercial Team in January 2017, Russell has been part of the Business Development team driving new project opportunities to our global facilities that would utilize our manufacturing capabilities for oral solid dose and sterile fill and finish drug products. Russell is currently VP of Business Development based in London.

Russell began his career working in manufacturing for Glaxo-Wellcome. In 2000, he moved into a procurement role sourcing contract manufacturing services for GSK. In 2004, he moved to Abbott Laboratories in a Director role responsible for sourcing indirect and direct services. In 2011, he returned to GSK as the Business Development Director, promoting manufacturing capacity from GSK’s global footprint.

Russell holds a BA (with honors) from The University of Kent, UK.

Lindsay Caithness, Ph.D.

Chief Commercial Officer

Dr. Lindsay Caithness has more than 20 years of experience in the pharmaceutical industry, with roles in Research & Development, Projects and Proposals Management, Pharmaceutical Development and Manufacturing, Clinical Services and Supply Management, and Commercial processes.

Since joining Avara's Corporate Team in mid-2018, Lindsay has been responsible for optimizing Avara's global processes and systems across customer service, project management, and commercial functions. Since transitioning into her current role, Lindsay has applied her prior experience to lead Avara’s Commercial Strategic and Marketing Plans and is in the process of executing these with her Business Development colleagues.

Lindsay held global leadership positions at Catalent Pharma Solutions and Aptuit CDMOs, responsible for global Project and Proposals Management to support Business Development for commercial and clinical supplies. Lindsay began her pharmaceutical career with Dabur Oncology, a start-up cytotoxin manufacturing facility (now owned by Fresenius Kabi), before moving to Fisher Clinical Services as a Project Manager, leading global clinical manufacturing and supply projects for Clients. She has also managed outsourcing activities at GlaxoSmithKline for European and Asia-Pacific clinical supplies.

Lindsay has a BSc in Biochemistry from The University of St Andrews, UK, and a PhD in Molecular Toxicology and Pharmacology from The University of Surrey, UK.

Mohan R. Gajjala

Vice President, Information Technology

Mohan R. Gajjala is a proven Global Pharmaceutical and Biotechnology leader with more than 29 years of leadership and technology experience. Mohan has a successful record of developing and leading global organizations, achieving strategic objectives, talent development and delivering tangible business results in pharmaceutical, technology, automotive and engineering industries.

Mohan is accomplished at helping IT departments become a value proposition for their organizations. In a career defined by collaboration and results, Mohan is both a turnaround architect of the highest order and someone able to grow and develop an entire IT organization.

Recently, Mohan has led the development of IT strategies for Multiple supply chains of GlaxoSmithKline Pharmaceuticals and Medimmune (AstraZeneca). This includes global ERP, supply chain, commercial, business and regulated environments coupled with a vendor partnership operating model.
Mohan joined Avara Pharmaceutical Services in January 2019.

Mohan holds a bachelor's degree in Mechanical Engineering from University of Mysore, India.

Andrea Baiocchi

Vice President and Site Director, Liscate Italy

Andrea Baiocchi is a proven leader with over 20 years of experience in the pharmaceutical industry. Andrea began his career with Pfizer in 1997 at the former Pharmacia & Upjohn headquarters in Milan Italy as a Business Control Analyst and moved to the Ascoli Italy site in 1998.

As the Director of Finance in 2001 Andrea drove the integration of Pharmacia into Pfizer as a team member and team leader. In 2006, Andrea was appointed Finance Director for the Ascoli and Nerviano, Italy sites and in February 2008, he was appointed Director, Materials Management at the Ascoli Italy site.

In September 2015, Andrea assumed the role of Site Integration Leader for Liscate Italy as part of the Pfizer acquisition of Hospira Inc. In December 2016 he was named Site Leader of the Liscate Italy, Sterile Injectable site and appointed to drive the site transition out of the Pfizer Network which concluded with the site sale to Avara Pharmaceutical Services in September 2017.

In December 2017 Andrea joined Avara Pharmaceutical Services as The VP & Site Director for the Liscate, Italy Sterile injectable site. Under his guidance and with the dedication of his leadership team they have successfully transition the activities of the site to a Contract Manufacturing Organization (CMO).

Andrea is Certified in Production and Inventory Management (CPIM) and a Certified Supply Chain Professional (CSCP).

Andrea has a degree in Business Economics from the Politecnico delle Marche Institute and an M.B.A. in Business Management from ISTAO - Istituto Adriano Olivetti, Ancona / Italy.

Idalia M. Garcia

Vice President and Site Director, Arecibo Puerto Rico

Idalia M. Garcia has over 24 years of experience in the pharmaceutical industry with leadership roles in Technical Operations, Quality Operations and Production Management. Her experience has provided a comprehensive understanding of pharmaceutical solid dosage forms manufacturing as well as the technical, regulatory and business aspects required to achieve success for the site and the Arecibo customers.

Idalia began her career with Eli Lilly as Process Scientist working on technical transfers before moving to Merck as Process Scientist in Technical roles. Idalia held site and regional leadership roles at Merck, as the Technical Director, Quality Director - External Partners and ultimately Operations Director, Latin America.

Idalia has successfully achieved business results and implemented organizational changes while providing development opportunities to site leadership and their team members. She has demonstrated success in achieving customer/patient goals through multiple interactions with suppliers, customers and regulatory authorities.

Idalia had led the Arecibo site through the divestiture process from Merck to Avara in 2015, prior to assuming the Site VP role at Arecibo for Avara. Since joining Avara in 2015, Idalia has been leading the Arecibo site through the transition to a CMO business model while maintaining continuity of supply to our customers.

Idalia has a BSc in Pharmacy and MSc in Industrial Pharmacy from University of Puerto Rico.

Tim D. Fogle

Vice President, Finance

Tim Fogle has 20+ years of experience in the pharmaceutical and manufacturing industries with senior roles in cost accounting as well as managerial roles in accounting and finance. Tim is an accomplished leader with vast experience in all aspects of accounting, financial reporting, budgeting and planning, system implementation, and internal controls. In addition, Tim has utilized his In-depth knowledge of applying Generally Accepted Accounting Principles (GAAP) in a manufacturing setting, to successfully accomplish outstanding audit results.

Tim began his career in cost accounting working in the energy services and IT space. The last 15 years he has held roles in the pharmaceutical manufacturing space as a cost accountant, accounting manager and controller for the Norman facility. Since joining Avara’s Corporate Finance Team in August 2016, Tim has been responsible for accounting and financial reporting across multiple sites in the Avara network. Our facilities manufacture oral solid dose and sterile fill and finish drug products. Tim has held roles with increasing responsibilities and was appointed to his current role of VP, Finance NA in April 2019. Tim is based at our Corporate Headquarters in Norman, Oklahoma.

Tim holds a Bachelor of Business Administration in Accounting from Oklahoma City University and a Master of Business Administration (MBA) from University of Oklahoma. In addition, Tim holds a Certified Managerial Accountant License (CMA).

Patrick D. Hatem

Vice President and Site Director, Aiken South Carolina

Patrick D. Hatem has 27 years of industry experience including 20 years in management roles with progressively increasing responsibilities in contract manufacturing organizations as well as specialty pharmaceutical companies. Through his experience he has established a foundation of development, analytical, quality/regulatory, manufacturing and supply chain expertise which allowed him to successfully lead new product launches in the North America, South America and Europe as both a submission sponsor and as a submission partner.

Joining Avara in August 2019, Patrick is the VP and Site Director for our Aiken South Carolina manufacturing facility. With his experience as both a contract provider and contract manager he will leverage this perspective to drive world class customer service meeting the needs of Avara’s customers.

Patrick began his career with Roxane Laboratories, ICN Pharmaceuticals and AAI Pharmaceuticals with roles in Product Development, Analytical Development, Quality Control, Validation, Technical Services and Manufacturing. In 2006 he joined Osmotica Pharmaceuticals to lead the management of their contract manufacturers and supply chain. Prior to Avara Patrick was the VP Manufacturing at UPM Pharmaceuticals building on their foundation of strong early phase development in Baltimore, MD to a largescale commercial supplier in Bristol, TN. Driving UPM’s growth with a combination of site legacy products, contract development products and direct site transfers.

Patrick holds a Bachelor of Science degree in Biology from Ohio Dominican University in Columbus, OH.

Flor D. Rivera Davila

Vice President Quality Assurance / Regulatory Affairs, North America

Flor D. Rivera Davila has more than 22 years of experience in the pharmaceutical industry in Plant Management and Operations roles along with a strong focus on quality and compliance.

For the past two years, Flor has served as the Director, Quality for Avara's Arecibo site. During that time, she oversaw the site's successful re-start following Hurricanes Irma and Maria, including managing the site's quality actions completion and documentation.

Flor holds a Bachelor of Science in Biology from the University of Puerto Rico, Rio Piedras Campus and holds an MT certification from the Puerto Rico Department of Health and the American Association of Clinical Pathologists.

Deborah A. Graham

Vice President and Site Director, Norman Oklahoma

Debbie Graham has been instrumental in the success of the Norman site, where she garnered more than 17 years of experience in the pharmaceutical industry with increasing leadership roles in Process Engineering, Project Management, Engineering, and Validation.

Debbie has a strong background in leading complex teams inside of oral solid dose manufacturing technologies. Since joining Avara in August 2016, she has been responsible for oversight of the Technical Services and Engineering departments, including facilities management of the Norman campus. In addition, she directed all aspects of the customer-facing portion of the business, including project management of new business, technical execution of product transfers and validation, and ongoing technical support for commercial products. She was promoted in January 2020 to VP and Site Director for the Norman Oklahoma manufacturing facility.

Debbie holds a Bachelor of Science degree and a Master of Science degree, both in Industrial Engineering, from The University of Oklahoma.